medmix AG

Swiss Stock Exchange MEDX.SW

medmix AG Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -95.73 M

medmix AG Net Cash Used For Investing Activities is USD -95.73 M for the year ending December 31, 2023, a -55.31% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • medmix AG Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -61.64 M, a -1,604.11% change year over year.
  • medmix AG Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -3.62 M, a -172.78% change year over year.
  • medmix AG Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD 4.97 M, a 112.16% change year over year.
  • medmix AG Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -40.88 M, a -21.32% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
Swiss Stock Exchange: MEDX.SW

medmix AG

CEO Ms. Jennifer Dean
IPO Date Oct. 4, 2021
Location Switzerland
Headquarters Dammstrasse 19
Employees 2,695
Sector Healthcare
Industries
Description

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.

Similar companies

SLHN.SW

Swiss Life Holding AG

USD 808.02

-1.39%

SUN.SW

Sulzer Ltd

USD 155.63

-4.65%

VACN.SW

VAT Group AG

USD 378.40

-2.39%

SRAIL.SW

Stadler Rail AG

USD 21.75

-2.31%

StockViz Staff

February 5, 2025

Any question? Send us an email